Chromosome involved in Myotonic Dystrophy is
**Question:** Chromosome involved in Myotonic Dystrophy is
A. Chromosome 19
B. Chromosome 22
C. Chromosome 14
D. Chromosome X
**Core Concept:**
Myotonic Dystrophy is a group of genetic disorders characterized by muscle weakness, wasting, and tendon reflex abnormalities. These disorders are caused by mutations in specific genes located on specific chromosomes. The two primary types of Myotonic Dystrophy are Myotonic Dystrophy Type 1 (DM1) and Myotonic Dystrophy Type 2 (DM2). DM1 is caused by mutations in the DMN1 gene located on Chromosome 19, while DM2 is caused by mutations in the CNBP gene located on Chromosome 19. In this case, the correct answer is Chromosome 19.
**Why the Correct Answer is Right:**
DM1 is caused by a repeat expansion mutation in the 3'UTR region of the DMPK gene, leading to the production of a toxic RNA secondary structure. This toxic RNA structure results in the impairment of multiple cellular functions, including muscle cell function. Chromosome 19 is the correct answer because the DMN1 gene, which contains the DMPK gene, is located on this chromosome.
**Why Each Wrong Option is Incorrect:**
DM2 is caused by mutations in the CNBP gene, which is located on Chromosome 19 as well. However, this is not the correct answer because the question asks for the chromosome associated with Myotonic Dystrophy Type 1 (DM1), not Type 2 (DM2).
C. Chromosome 14 is incorrect because Myotonic Dystrophy is not associated with this chromosome.
D. Chromosome X is incorrect because DM1 and DM2 are autosomal dominant disorders, not X-linked.
**Clinical Pearl:**
Understanding the genetic basis of Myotonic Dystrophy is essential for healthcare professionals to accurately diagnose and counsel patients and their families about the inheritance pattern and potential consequences of these disorders. Chromosome 19 is crucial for recognizing DM1, while Chromosome X is important for understanding X-linked disorders like Duchenne Muscular Dystrophy, which is also a neuromuscular disorder but has a different genetic basis.
By understanding the genetic basis of these disorders, healthcare professionals can provide appropriate genetic counseling and management strategies for patients and their families, allowing for early detection, intervention, and support. Additionally, this knowledge is crucial for recognizing the genetic basis of various neuromuscular disorders and differentiating them from other conditions with similar symptoms, such as Duchenne Muscular Dystrophy, which is caused by mutations in the DMD gene located on X chromosome.